- Home
- SUPN vs CNMD Comparison
SUPN vs CNMD Comparison
Compare SUPN & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- CNMD
- Stock Information
- Founded
- SUPN 2005
- CNMD 1970
- Country
- SUPN United States
- CNMD United States
- Employees
- SUPN N/A
- CNMD N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SUPN Health Care
- CNMD Health Care
- Exchange
- SUPN Nasdaq
- CNMD Nasdaq
- Market Cap
- SUPN 1.9B
- CNMD 1.7B
- IPO Year
- SUPN 2012
- CNMD 1987
- Fundamental
- Price
- SUPN $31.70
- CNMD $54.33
- Analyst Decision
- SUPN Hold
- CNMD Hold
- Analyst Count
- SUPN 2
- CNMD 5
- Target Price
- SUPN $36.00
- CNMD $62.20
- AVG Volume (30 Days)
- SUPN 685.5K
- CNMD 418.9K
- Earning Date
- SUPN 08-05-2025
- CNMD 07-30-2025
- Dividend Yield
- SUPN N/A
- CNMD 1.47%
- EPS Growth
- SUPN N/A
- CNMD 46.38
- EPS
- SUPN 1.11
- CNMD 3.81
- Revenue
- SUPN $667,997,000.00
- CNMD $1,315,998,000.00
- Revenue This Year
- SUPN N/A
- CNMD $6.27
- Revenue Next Year
- SUPN $12.02
- CNMD $5.62
- P/E Ratio
- SUPN $28.89
- CNMD $14.26
- Revenue Growth
- SUPN 11.82
- CNMD 4.32
- 52 Week Low
- SUPN $25.55
- CNMD $46.00
- 52 Week High
- SUPN $40.28
- CNMD $78.19
- Technical
- Relative Strength Index (RSI)
- SUPN 48.95
- CNMD 49.86
- Support Level
- SUPN $30.93
- CNMD $51.43
- Resistance Level
- SUPN $32.78
- CNMD $55.19
- Average True Range (ATR)
- SUPN 1.00
- CNMD 1.55
- MACD
- SUPN -0.03
- CNMD 0.18
- Stochastic Oscillator
- SUPN 46.56
- CNMD 76.74
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.